82257-16-7

Basic information

• Product Name: 3-Pyridinecarboxaldehyde, 4-(methylthio)- (9CI)
• Synonyms: 3-Pyridinecarboxaldehyde, 4-(methylthio)- (9CI);4-(methylthio)nicotinaldehyde
• CAS NO: 82257-16-7
• Molecular Formula: C7H7NOS
• Molecular Weight: 153.20158
• Product Categories: ALDEHYDE
• Mol File: 82257-16-7.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-Pyridinecarboxaldehyde, 4-(methylthio)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Pyridinecarboxaldehyde, 4-(methylthio)- (9CI)(82257-16-7)
• EPA Substance Registry System: 3-Pyridinecarboxaldehyde, 4-(methylthio)- (9CI)(82257-16-7)

Safety Data

• Hazardous Substances Data: 82257-16-7(Hazardous Substances Data)

Upstream product

• 114077-82-6 4-chloronicotinaldehyde 
• 5188-07-8 sodium thiomethoxide 

Downstream Products

• 688356-75-4 methyl 4-(methylthio)-1H-pyrrolo[2,3-b]pyridine-2-carboxylate 

Relevant articles and documents

Method of Treating Pathological Blushing

A method of treating pathological blushing is disclosed wherein the patient is administered a DP receptor antagonist. Compositions containing DP antagonists are also included.

METHOD OF TREATING ATHEROSCLEROSIS, DYSLIPIDEMIAS AND RELATED CONDITIONS

A method of treating atherosclerosis, dyslipidemia and related conditions is disclosed wherein a compound of formula I: or a pharmaceutically acceptable salt or solvate thereof is administered to the patient in combination with a DP receptor antagonist. T

NIACIN RECEPTOR AGONISTS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT

The present invention relates to niacin receptor agonists of formula: (I); as well as pharmaceutically acceptable salts and solvates. The compounds are useful for treating dyslipidemias, and in particular, reducing serum LDL, VLDL and triglycerides, and raising HDL levels. Pharmaceutical compositions and methods of treatment are also included.